Periodic Reporting for period 1 - 3DCC (Ready-to-use 3D Cell Cultures for early de-risking in drug development)

Summary
"What is the problem being addressed?The current rate of failure during development for getting new drugs to cancer patients is outrageously high (around 95%). Most of these failures can be attributed to unacceptable toxicity during clinical trials or more often to lack of...
More information & hyperlinks